DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones
The Impact of Suction-Assisted RIRS (DISS Versus FANS) on Postoperative Infection Rate and Stone-Free Rate After Treatment of Medium Sized Renal Stones
1 other identifier
interventional
126
1 country
1
Brief Summary
Kidney stones are a common health problem and may recur frequently, which can affect quality of life and kidney function. Retrograde intrarenal surgery (RIRS) is a minimally invasive treatment used for renal stones, but treatment of medium-sized stones may be associated with longer operative time, impaired visibility during surgery, residual stone fragments, and postoperative infectious complications caused by increased intrarenal pressure. Suction-assisted retrograde intrarenal surgery (RIRS) techniques have been developed to improve surgical efficiency and safety by facilitating continuous removal of stone fragments and helping control intrarenal pressure. Two commonly used suction-assisted approaches are direct in-scope suction (DISS) and flexible and navigable suction ureteric access sheath (FANS). However, there is limited prospective randomized evidence directly comparing these two techniques. This randomized prospective clinical study aims to compare direct in-scope suction (DISS) versus flexible and navigable suction ureteric access sheath (FANS) in adult patients with medium-sized renal stones measuring 2 to 3 cm who are undergoing retrograde intrarenal surgery (RIRS). Participants will be randomly assigned to one of the two suction-assisted techniques. The study will evaluate whether flexible and navigable suction ureteric access sheath (FANS) provides better outcomes than direct in-scope suction (DISS) in terms of stone-free rate and postoperative infection rate. The primary outcome is stone-free status assessed by postoperative imaging. Secondary outcomes include operative time, intraoperative visibility, and postoperative complications, particularly infection and urosepsis. The study hypothesis is that suction-assisted retrograde intrarenal surgery (RIRS) using the flexible and navigable suction ureteric access sheath (FANS) technique will result in a higher stone-free rate and a lower postoperative infection rate compared with direct in-scope suction (DISS) in the management of medium-sized renal stones.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 1, 2026
CompletedFirst Posted
Study publicly available on registry
April 8, 2026
CompletedStudy Start
First participant enrolled
April 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 30, 2027
April 8, 2026
April 1, 2026
1 year
April 1, 2026
April 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Stone-Free Rate
Stone-free status will be assessed by postoperative imaging using kidney, ureter, and bladder radiography and non-contrast computed tomography. Clinically insignificant residual fragments will be defined as residual fragments measuring 2 to 3 millimeters or less.
At 1 month after surgery
Secondary Outcomes (4)
Postoperative Infection Rate
Within 1 month after surgery
Operative Time
During surgery (Intraoperatively)
Intraoperative Visibility Score
During surgery (Intraoperatively)
Postoperative Complication Rate
Within 1 month after surgery
Study Arms (2)
In-Scope Suction Group
EXPERIMENTALParticipants assigned to this arm will undergo suction-assisted retrograde intrarenal surgery using direct in-scope suction. A single-use flexible ureteroscope with suction function will be used, and direct suction will be applied through the working channel during laser lithotripsy. Negative pressure will be maintained between 2 and 7 kilopascals and adjusted intraoperatively according to visibility and fragment evacuation. Laser lithotripsy will be performed using a holmium:yttrium-aluminum-garnet laser with dusting and popcorn techniques, followed by placement of a 6 French double-J ureteral stent.
Flexible and Navigable Suction Ureteric Access Sheath Group
EXPERIMENTALParticipants assigned to this arm will undergo suction-assisted retrograde intrarenal surgery using a flexible and navigable suction ureteric access sheath. The sheath will be inserted under guidewire guidance and connected to a vacuum device. Negative pressure will be maintained between 2 and 7 kilopascals and adjusted intraoperatively according to visibility and fragment evacuation. Laser lithotripsy will be performed using a holmium:yttrium-aluminum-garnet laser with dusting and popcorn techniques. Suction will be applied intermittently through the sheath to facilitate fragment evacuation, followed by placement of a 6 French double-J ureteral stent.
Interventions
Direct suction is applied through the working channel of the flexible ureteroscope during retrograde intrarenal surgery to facilitate evacuation of stone fragments and improve intraoperative visibility during laser lithotripsy.
A flexible and navigable suction ureteric access sheath is used during retrograde intrarenal surgery to provide suction-assisted evacuation of stone fragments, improve visibility, and support intrarenal pressure control during laser lithotripsy.
Eligibility Criteria
You may qualify if:
- Adults aged 18 to 60 years
- Radiologically confirmed renal stones measuring 2 to 3 centimeters
- Eligible for retrograde intrarenal surgery
- Normal renal function as evidenced by normal serum creatinine
- Able and willing to provide written informed consent
You may not qualify if:
- Pregnancy or lactation
- Active urinary tract infection at the time of enrollment
- Bleeding disorders or coagulopathies that contraindicate surgical intervention
- Anatomical malformations affecting the urinary tract
- Solitary kidney
- Inability or unwillingness to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain Shams University Hospitals
Cairo, 11511, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- This is an open-label surgical trial. The operating urologist cannot be masked because the two suction-assisted retrograde intrarenal surgery techniques require different instruments and procedural steps. Participants will undergo one assigned procedure according to the study protocol. Outcome assessment will be based on predefined clinical, laboratory, and imaging measures.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident of Urology
Study Record Dates
First Submitted
April 1, 2026
First Posted
April 8, 2026
Study Start
April 30, 2026
Primary Completion (Estimated)
April 30, 2027
Study Completion (Estimated)
April 30, 2027
Last Updated
April 8, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Data will become available beginning 6 months after publication of the main study results and will remain available for 5 years.
- Access Criteria
- Data will be available to qualified researchers who provide a methodologically sound research proposal. Requests should be directed to the corresponding investigator. Access will be granted after review and approval of the proposal and execution of a data access agreement, with use limited to the purposes described in the approved proposal.
De-identified individual participant data underlying the results reported in this study will be made available, including demographic data, baseline characteristics, intervention allocation, outcome measures, and adverse event data.